Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02256436 |
|---|---|
| Brief Title: | A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045) |
| First Submitted : | September 29, 2014 |
| First Submitted that Met QC Criteria : | October 2, 2014 |
| First Posted : | October 3, 2014 (Estimate) |
| Results First Submitted : | June 12, 2017 |
| Results First Submitted that Met QC Criteria : | July 28, 2017 |
| Results First Posted : | August 31, 2017 |
| Last Update Submitted that Met QC Criteria : | August 23, 2021 |
| Last Update Posted : | September 20, 2021 |